Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

For implantable drug systems and neurological electrodes, adding radiopacity ensures that providers can monitor placement and fine-tune positioning over time. Devices like hydrocephalus shunts and ...

Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based ...

“On February 21, 2025, the Operator of the Nungua Sea Water Desalination Plant informed GWL that due to a technical problem encountered with respect to the final delivery pumps at their ...